Skip to main content
Caplight Logo









Elarex Inc.

Elarex Inc.

Private
BurlingtonHealthcare & Life Scienceshttps://elarexinc.com/

Last Round

Grant

Sep 1, 2022

Total Funding Raised

$1.08M

Company Overview

Elarex Inc. is a biotechnology company that develops proprietary stabilization technology to improve the temperature stability of vaccines and biologic drugs, aiming to eliminate the need for cold-chain transportation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

cold chainvaccine stabilizationbiologic drug storageroom temperature storagemRNA therapeuticsbiotech formulationpharma supply chaindrug delivery technologythermostable vaccinescold chain logisticsbiotech licensingLNP therapeuticslast mile deliverycold chain breakagebiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elarex Inc. Comparables

Compare Elarex Inc. with similar companies based on industry and business-model similarity.

Elarex Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Inaedis Inc.
88%
EnsiliTech
87%
Jurata Thin Film
87%

Elarex Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2022
GrantNov 4, 2021

Elarex Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors grew 9511% MoM, from 9 to 865.

  • Dec 4, 2023

    Grew 43% QoQ, from 7 to 10 employees.

Elarex Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Elarex Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elarex Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBurlington
Employee Range5
Year Founded2019
Last FundingSep 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?